Mylan offers discounts on EpiPen amid criticism
It is latest firm to be caught up in outrage at apparently egregious drug price increases
New York
MYLAN NV said on Thursday it would reduce the out-of-pocket costs of its emergency EpiPen allergy injection for some patients amid a wave of criticism from lawmakers and the public over the product's rapidly escalating price.
The list price of the drug will remain the same, but the company said it would increase the maximum copay assistance programme to US$300 from US$100 for patients who pay for the 2-pak in cash or who are covered by a commercial health insurer.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Another Cordlife director arrested amid CAD probe
Genting chairman says open to casino resort development in UAE
Spotify sued over alleged unpaid royalties
Under Armour forecasts downbeat annual sales and profit, shares slump
J&J to acquire Proteologix for US$850 million
Watches of Switzerland sees used watch sales double